Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00344162 · ClinicalTrials.gov registry record

Family Study on Preeclampsia

A clinical trial of Preeclampsia, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

Completed
Registry status
1,000
Enrollment target
1
Study location

NCT00344162: Completed study of Preeclampsia, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

NCT00344162 is a study of Preeclampsia that has completed, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The registered enrollment target is 1,000 participants, below the 1,105-participant average among 48 other Preeclampsia trials with a reported enrollment target (10% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00344162, a study of Preeclampsia, has completed, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

COMPLETED
Registry status
1,000 participants
Enrollment target
1
Study location

Study Summary

This study will examine a possible genetic basis for preeclampsia, a disorder of high blood pressure and protein in the urine during pregnancy. Preeclampsia is a major pregnancy complication affecting both mother and baby. Previous research has shown that preeclampsia tends to run in certain families. This study will determine which genes may be involved in preeclampsia. Women who have had preeclampsia (called the index woman) may be eligible for this study. They will be recruited through the Preeclampsia Foundation. In addition, the following relatives of the index woman may be enrolled: * The child from the preeclampsic pregnancy * The index woman's biological parents * The index woman's siblings who have given birth or fathered a child and their family members The study will exclude any index women or family members who have had chronic hypertension, diabetes, polycystic ovary syndrome, or whose pregnancy that involved preeclampsia was a multiple fetus pregnancy or that was conceived through use of fertility technology. All women participants fill out a questionnaire to collect demographic data (e.g., age, race, marital status, etc.) and information on their medical and reproductive history, use of tobacco and medicines, and other factors that may be associated with preeclampsia syndrome. Women who have had preeclampsia or hypertension in pregnancy are asked to sign a medical record release form for study investigators to obtain a copy of the medical record for that pregnancy. All male and female participants provide a mouthwash rinse sample for extraction of DNA for gene studies. For babies too young to rinse with mouthwash, a soft brush is used to brush the inside of the mouth to collect cheek cells. Mouthwash samples are analyzed for genes that may be associated with preeclampsia.

Conditions Studied

Study Locations (1)

Maryland

  • National Institute of Child Health and Human Development (NICHD) - Bethesda

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2005-01-31
Est. Completion 2006-09-22

What the finished NCT00344162 record still lists

NCT00344162 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 1,105-participant average among 48 other Preeclampsia trials with a reported enrollment target (10% lower).

The record links to 1 condition, with Preeclampsia appearing as the primary indexed condition, and to 0 interventions.

NCT00344162 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT00344162 about?

NCT00344162 is a clinical study titled "Family Study on Preeclampsia". This study will examine a possible genetic basis for preeclampsia, a disorder of high blood pressure and protein in the urine during pregnancy. Preeclampsia is a major pregnancy complication affecting both mother and baby. Previous research has shown that preeclampsia tends to run in certain familie...

What is the current status of trial NCT00344162?

This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2005-01-31. Estimated completion is 2006-09-22.

What conditions does trial NCT00344162 study?

This clinical trial studies the following conditions: Preeclampsia.

Who is sponsoring clinical trial NCT00344162?

This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00344162 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Preeclampsia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00344162's enrollment target sits among peer trials

1,000 7th of 48 higher than 41 of 48 other Preeclampsia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Preeclampsia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00344162, the US trial registry maintained by the National Library of Medicine. NCT00344162 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.